Windlas Biotech Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
WINDLAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Windlas Biotech has submitted a routine compliance certificate to the stock exchanges for the quarter ended December 31, 2025. The certificate was issued by MUFG Intime India, the company's Registrar and Share Transfer Agent. It confirms that no dematerialization requests were received or processed during the quarter. The filing also notes that the company holds no physical shares, meaning all shares are already in demat form.
This is a standard procedural filing with no material impact on the business or shareholders. It simply confirms routine regulatory compliance regarding share dematerialization.